Survey on cannabis use in Parkinson's disease: subjective improvement of motor symptoms
Language English Country United States Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
15372606
DOI
10.1002/mds.20111
Knihovny.cz E-resources
- MeSH
- Marijuana Abuse epidemiology MeSH
- Adult MeSH
- Cannabinoids administration & dosage therapeutic use MeSH
- Middle Aged MeSH
- Humans MeSH
- Parkinson Disease diagnosis epidemiology MeSH
- Prevalence MeSH
- Surveys and Questionnaires * MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Severity of Illness Index MeSH
- Treatment Outcome MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Cannabinoids MeSH
An anonymous questionnaire sent to all patients attending the Prague Movement Disorder Centre revealed that 25% of 339 respondents had taken cannabis and 45.9% of these described some form of benefit.
References provided by Crossref.org
Cannabis Therapeutics and the Future of Neurology